Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6209728

Cc1ccccc1-c1ccccc1S(=O)(=O)c1csc(C(=N)N)c1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
C1S P09871 7/20 0.43
HDAC4 P56524 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PRSS1 P07477 7/20 0.36
PRSS2 P07478 7/20 0.36
PRSS3 P35030 7/20 0.36
F10 P00742 5/20 0.36
F2 P00734 5/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NAMPT P43490 1/20 0.35
HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5840067 0.85 C1S (0.55) C1SPRSS1PRSS2PRSS3F10
SCHEMBL8363623 0.75 C1S (0.62) C1S
Trifluoroacetic Acid SCHEMBL5841624 0.73 C1S (0.66) C1S
Trifluoroacetic Acid SCHEMBL5840720 0.73 C1S (0.65) C1S
Trifluoroacetic Acid SCHEMBL5840908 0.73 C1S (0.65) C1S
Trifluoroacetic Acid SCHEMBL5840978 0.73 C1S (0.64) C1S
Trifluoroacetic Acid SCHEMBL5841031 0.71 C1S (0.86) C1S
Trifluoroacetic Acid SCHEMBL5840250 0.71 C1S (0.59) C1S
Trifluoroacetic Acid SCHEMBL6209316 0.70 C1S (0.59) C1S
Trifluoroacetic Acid SCHEMBL5840256 0.69 C1S (0.67) C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549632-A4 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS DIMENSIONAL PHARM INC (US) 2005-11-09 EP disclosed
EP-1549632-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-07-06 EP disclosed
WO-2003099805-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-12-04 WO disclosed